Selected article for: "SARS cell and significant increase"

Author: Méndez-Sánchez, Nahum; Valencia-Rodríguez, Alejandro; Qi, Xingshun; Yoshida, Eric M.; Romero-Gómez, Manuel; George, Jacob; Eslam, Mohammed; Abenavoli, Ludovico; Xie, Weifen; Teschke, Rolf; Carrion, Andres F.; Keaveny, Andrew P.
Title: What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective
  • Document date: 2020_4_11
  • ID: tiixwaqi_8
    Snippet: A recent mouse model of acute liver injury with partial hepatectomy found that at day 1 post-hepatectomy, hepatic expression of ACE2 in rats was downregulated. From day 3, there was an up to two-fold increased expression of this receptor, with a normalization of values on day 7, when the liver recovered and hepatocyte proliferation ceased. 17 With this information, the authors proposed that the systemic inflammation derived from significant NCP c.....
    Document: A recent mouse model of acute liver injury with partial hepatectomy found that at day 1 post-hepatectomy, hepatic expression of ACE2 in rats was downregulated. From day 3, there was an up to two-fold increased expression of this receptor, with a normalization of values on day 7, when the liver recovered and hepatocyte proliferation ceased. 17 With this information, the authors proposed that the systemic inflammation derived from significant NCP could trigger liver necrosis and hepatocyte proliferation, upregulating the expression of ACE2 and therefore worsening liver injury. Similarly, liver biopsies from SARS-CoV patients showed a significant increase in mitotic cell numbers, with eosinophilic bodies and balloon-like hepatocytes, 18 supporting a role for SARS-CoV-2 in the development of liver injury.

    Search related documents:
    Co phrase search for related documents
    • liver injury and partial hepatectomy: 1, 2, 3, 4
    • liver injury and receptor increase expression: 1, 2
    • liver injury and SARS CoV patient: 1, 2, 3, 4, 5
    • liver injury and SARS role: 1, 2, 3, 4, 5, 6
    • liver injury and significant increase: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • liver injury and systemic inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
    • liver injury development and significant increase: 1
    • liver injury development and systemic inflammation: 1, 2
    • liver necrosis and mouse model: 1, 2
    • liver necrosis and significant increase: 1
    • mouse model and partial hepatectomy: 1, 2
    • mouse model and SARS CoV patient: 1, 2, 3, 4, 5, 6, 7
    • mouse model and SARS role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • mouse model and significant increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • mouse model and systemic inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • receptor increase expression and significant increase: 1
    • SARS CoV patient and significant increase: 1, 2, 3, 4, 5, 6, 7
    • SARS CoV patient and systemic inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • SARS role and significant increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15